The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.

The FENYX is valveless and able to self-prime 10x-40x faster than a syringe pump, helping OEMs eliminate unnecessary fluidic components such as flushing pumps, prime pumps, selector valves, and tubing ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...